A method is provided for treating a targeted area of ocular tissue in a tissue-sparing manner comprising use of two or more therapeutic modalities, including thermal radiation source (such as an CW infrared fiber laser), operative in a wavelength range that has a high absorption in water, and photochemical collagen cross-linking (CXL), together with one or more specific system improvements, such as pen-operative feedback measurements for tailoring of the therapeutic modalities, an ocular tissue surface thermal control/cooling mechanism and a source of deuterated water/riboflavin solution in a delivery system targeting ocular tissue in the presence of the ultraviolet radiation. Additional methods of rapid cross-linking (RXL), are provided that enables cross-linking (CXL) therapy to be combined with thermal therapy.

Microsurgical instruments having combined illumination, laser ablation, and viscoelastic injection functions. A surgical instrument includes a probe having a main lumen and a port at a distal end thereof. The probe may further include one or more optical fibers within the main lumen, the optical fibers configured to project laser light and illumination light. Laser light may be emitted from the distal end of the probe for disrupting an ocular tissue, while illumination light may be simultaneously emitted, axially or laterally, to provide enhanced visualization of the intraocular space during tissue disruptance. Upon disrupting the tissue, a viscoelastic fluid may be injected from the port to maintain an integrity of the intraocular space.

An intraocular cyclophotocoagulation device having a proximal, reusable portion and a distal, disposable portion. The reusable portion includes laser treatment assembly comprising a laser diode and a collimating lens positioned a distance distal to the laser diode and configured to collimate light from the laser diode into a collimated laser beam and direct the collimated laser beam towards a distal end region of the proximal housing portion; and an imaging assembly. The disposable portion includes a laser guide extending through an elongate shaft and an aspheric lens positioned within the distal housing portion to receive the collimated laser beam from the proximal reusable portion and direct the collimated laser beam toward a proximal end of a fiberoptic of the laser guide and an illumination light guide and an illumination source positioned within the distal housing portion. Related devices, systems, and methods are provided.

The present invention relates to an ophthalmic treatment apparatus and a control method therefor, the ophthalmic treatment apparatus comprising: a display unit for displaying an image of a patient's eyeground; a treatment region setting unit for setting a treatment region on the basis of the image of the patient's eyeground; a treatment light radiating unit for radiating treatment light to the set treatment region; a radiation density setting unit for setting radiation density of the treatment light radiated to the set treatment region; and a control unit for controlling the treatment light radiating unit so as to radiate the treatment light onto the set treatment region on the basis of the set density.

A treatment system for ophthalmic purposes with a base body and an articulated arm with an applicator for applying an examination or treatment to a patient's eye, which includes a locking device for the secure storage of the articulated arm.

Cataract surgery is in recent years more and more augmented and supported by the application of laser cuts in the eye tissue. Such laser systems are separate units from the phacoemulsification system units that are usually used for cataract extraction. The laser systems require the patient to be positioned under the laser unit and then being moved under the surgical microscope next to the phacoemulsification unit. The here described invention relates to systems combining several aspects of the laser system and the phacoemulsification system. In particular, this invention relates to combining at least some parts of the control system and the housing for both systems and thereby minimizing and optimizing setup time, operating room footprint, patient flow and cost. Furthermore the here disclosed invention relates to integrating the laser system under the surgical microscope and thereby significantly reducing the surgery setup and complexity.

A single-use laser probe with reusable optic fiber fixtures may include a transitory connector having a transitory connector distal end and a transitory connector proximal end; a tube having a tube distal end and a tube proximal end; and an optic fiber having an optic fiber distal end and an optic fiber proximal end. The optic fiber may be disposed in the transitory connector wherein the optic fiber proximal end extends a distance from the transitory connector distal end. The optic fiber may be disposed in the tube wherein the optic fiber distal end is coplanar with the tube distal end. The transitory connector may be configured to interface with a reusable optic fiber fixture.

An optical coherence tomography device includes an OCT optical system that irradiates a tissue of the subject's eye with measurement light from a light source, and detects interference between reference light and the measurement light reflected from the tissue by using a detector, and a processor, in which the processor performs a generation process of acquiring A-scan data based on a signal output from the detector in a cycle of 300 kilohertz or more and generating three-dimensional OCT data at any time based on the acquired A-scan data, and performs an analysis process on each piece of the three-dimensional OCT data generated at any time through the generation process, so as to output a real-time analysis result of the three-dimensional OCT data which is generated at any time.

A medical apparatus includes a treatment device configured to be capable of treating a subject by applying energy to the subject, an optical fiber including a light emitting face for emitting light into the subject, the optical fiber being connected to the treatment device, and a shield portion that is disposed in front of the light emitting face of the optical fiber, the shield portion being configured to expose the light emitting face when the treatment device does not perform a treatment operation and to shield the light emitting face when the treatment device performs the treatment operation.

A process that provides protective therapy for biological tissues or fluids includes applying a pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease to therapeutically or prophylactically treat the target tissue or target fluid. The pulsed energy source has energy parameters selected so as to raise the target tissue or bodily target fluid temperature up to a predetermined temperature for a short period of time to achieve a therapeutic or prophylactic effect, while the average temperature rise of the target tissue or target fluid over a longer period of time is maintained at or below a predetermined level so as not to permanently damage the target tissue or target fluid.